123 related articles for article (PubMed ID: 2450240)
21. Comparison of the cardiovascular and biochemical profiles of a new positive inotropic drug, AR-L 115 BS, with those of theophylline.
Morita T; Satoh K; Taira N
Jpn Heart J; 1984 May; 25(3):447-60. PubMed ID: 6088829
[TBL] [Abstract][Full Text] [Related]
22. Cardiovascular profile of Ro 40-5967, a new nondihydropyridine calcium antagonist, delineated in isolated, blood-perfused dog hearts.
Orito K; Satoh K; Taira N
J Cardiovasc Pharmacol; 1993 Aug; 22(2):293-9. PubMed ID: 7692172
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
[TBL] [Abstract][Full Text] [Related]
24. Cardiac versus coronary dilator effects of SD-3211, a new nondihydropyridine calcium antagonist, in isolated, blood-perfused dog hearts.
Yoneyama F; Yamada H; Satoh K; Taira N
Cardiovasc Drugs Ther; 1990 Dec; 4(6):1469-76. PubMed ID: 2081139
[TBL] [Abstract][Full Text] [Related]
25. Cardiac versus coronary vasodilator actions of isobutylmethylxanthine in dogs: comparison with theophylline.
Takahashi K; Wada Y; Taira N
Jpn J Pharmacol; 1986 May; 41(1):23-32. PubMed ID: 2426501
[TBL] [Abstract][Full Text] [Related]
26. Cardiac safety profile of sildenafil: chronotropic, inotropic and coronary vasodilator effects in the canine isolated, blood-perfused heart preparations.
Lubna NJ; Nakamura Y; Cao X; Wada T; Izumi-Nakaseko H; Ando K; Sugiyama A
J Toxicol Sci; 2016; 41(6):739-744. PubMed ID: 27853102
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular pharmacology of 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties.
Narimatsu A; Kitada Y; Satoh N; Suzuki R; Okushima H
Arzneimittelforschung; 1987 Apr; 37(4):398-406. PubMed ID: 3606694
[TBL] [Abstract][Full Text] [Related]
28. Similarity and dissimilarity in mode and mechanism of action between YT-146, a selective adenosine receptor A2 agonist, and adenosine in isolated canine hearts.
Yoneyama F; Aihara K; Kogi K; Satoh K; Taira N
Tohoku J Exp Med; 1999 May; 188(1):31-45. PubMed ID: 10494898
[TBL] [Abstract][Full Text] [Related]
29. Cardioselective effects of gallopamil compared with verapamil in the dog heart.
Takahashi K; Tsuchida K; Aihara H
Arch Int Pharmacodyn Ther; 1988; 295():157-73. PubMed ID: 3245731
[TBL] [Abstract][Full Text] [Related]
30. Cardiovascular profile of AN-132, a new diamine derivative antiarrhythmic agent, revealed in the isolated, blood-perfused dog heart.
Gotanda K; Satoh K; Taira N
Tohoku J Exp Med; 1988 Sep; 156(1):65-78. PubMed ID: 3194907
[TBL] [Abstract][Full Text] [Related]
31. In vitro characterization of the effects of MCI-154, a novel cardiotonic agent, on cardiac tissues.
Narimatsu A; Kitada Y; Satoh N; Morita M; Muroyama A; Kobayashi M; Ohizumi Y
Jpn J Pharmacol; 1989 Mar; 49(3):397-405. PubMed ID: 2545964
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular profile of Bay K 8644, a presumed calcium channel activator, in the dog.
Wada Y; Satoh K; Taira N
Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):382-7. PubMed ID: 2581147
[TBL] [Abstract][Full Text] [Related]
33. Contractile proteins: possible targets for the cardiotonic action of MCI-154, a novel cardiotonic agent?
Kitada Y; Narimatsu A; Matsumura N; Endo M
Eur J Pharmacol; 1987 Feb; 134(2):229-31. PubMed ID: 3569412
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms underlying the cardiovascular action of a new dihydropyridine vasodilator YC-93.
Satoh K; Yanagisawa T; Taira N
Clin Exp Pharmacol Physiol; 1980; 7(3):249-62. PubMed ID: 7406961
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular actions of OPC-18790: a novel positive inotropic agent with little chronotropic action.
Hosokawa T; Mori T; Fujiki H; Kinoshita S; Takemoto K; Imaizumi T; Noda T; Ohura M; Tominaga M; Yabuuchi Y
Heart Vessels; 1992; 7(2):66-75. PubMed ID: 1328145
[TBL] [Abstract][Full Text] [Related]
36. Inotropic and chronotropic profile of MCI-154: comparison with isoproterenol and imazodan in guinea pig cardiac preparations.
Allert JA; Adams HR
J Cardiovasc Pharmacol; 1990 Jul; 16(1):59-67. PubMed ID: 1696667
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the effects of MCI-154, a new cardiotonic agent, and some Ca2+-sensitizing agents on the response of the contractile system to Ca2+ in skinned cardiac muscle.
Kitada Y; Morita M; Narimatsu A
Jpn J Pharmacol; 1989 Aug; 50(4):411-9. PubMed ID: 2789299
[TBL] [Abstract][Full Text] [Related]
38. Comparison of cardiovascular effects of pirmenol with those of disopyramide in isolated canine heart preparations cross-circulated with a donor dog.
Sugiyama A; Motomura S; Tamura K; Hashimoto K
Jpn J Pharmacol; 1990 May; 53(1):97-110. PubMed ID: 2352380
[TBL] [Abstract][Full Text] [Related]
39. Pharmacological profile of a new coronary vasodilator drug, 2-nicotinamidoethyl nitrate (SG-75).
Taira N; Satoh K; Yanagisawa T; Imai Y; Hiwatari M
Clin Exp Pharmacol Physiol; 1979; 6(3):301-16. PubMed ID: 157241
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular profiles of the calcium antagonists nisoldipine and nifedipine in the blood-perfused dog heart.
Takahashi K; Taira N
Arzneimittelforschung; 1986 Jul; 36(7):1054-9. PubMed ID: 3768072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
